Phinomics
PrivateLast Round
Grant
May 15, 2023
Total Funding Raised
$1.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phinomics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Grant round in May 2023.
Phinomics is a biotechnology company developing genomic technologies designed to create circular deoxyribonucleic acid systems for unmet needs in healthcare.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phinomics Comparables
Compare Phinomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SOPHiA GENETICS | 70% | |
| CircNova | 67% | |
| Personalis Inc | 64% |
For institutional investors. Book with your work email.
Phinomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2023 | ||||
| Seed | Dec 31, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phinomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Creative Destruction Lab | Seed |
| The Elizabeth Elting Venture Fund | Grant, Seed |
| K5 Global | Seed |
| Silicon Catalyst | Seed |
| Springboard Health Angels | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Grew 33% QoQ, from 9 to 12 employees.
- Jun 27, 2026
Grew 50% QoQ, from 8 to 12 employees.
For institutional investors. Book with your work email.
Phinomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phinomics's valuation, stock price, and market status.
Is Phinomics a public or private company?
Phinomics is a private company.
What is the current stock price of Phinomics?
Phinomics is a private company, so its shares have no public market price. Caplight tracks Phinomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phinomics worth (valuation)?
Valuation information for Phinomics is not publicly available.
Can I buy Phinomics stock?
Phinomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phinomics's last funding round?
Phinomics's most recent funding round was Grant on May 15, 2023.
Who are the main investors in Phinomics?
Key investors in Phinomics include National Cancer Institute, NIH RADx, Creative Destruction Lab, The Elizabeth Elting Venture Fund, K5 Global.
Will Phinomics IPO soon?
No public IPO plans have been announced for Phinomics.
How can I track Phinomics secondary market activity?
Caplight tracks bids, offers, and trades in Phinomics's shares on secondary markets.